Published in J Clin Microbiol on April 01, 1994
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev (2010) 4.22
Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol (2000) 3.77
Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax (2004) 3.25
Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol (1996) 2.95
Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol (1997) 2.72
The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol (2008) 2.71
Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). J Clin Microbiol (2000) 2.63
Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis (1998) 2.43
Siderophore production by cystic fibrosis isolates of Burkholderia cepacia. Infect Immun (1998) 1.80
Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J Clin Microbiol (1995) 1.79
Comparative assessment of genotyping methods for epidemiologic study of Burkholderia cepacia genomovar III. J Clin Microbiol (2002) 1.79
Invasion and intracellular survival of Burkholderia cepacia. Infect Immun (2000) 1.74
Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun (2001) 1.74
The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia. Infect Immun (2004) 1.60
An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis (1999) 1.59
Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol (2001) 1.50
Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol (2002) 1.48
Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun (1998) 1.47
Involvement of a plasmid-encoded type IV secretion system in the plant tissue watersoaking phenotype of Burkholderia cenocepacia. J Bacteriol (2004) 1.40
Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe. Thorax (2004) 1.32
Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol (1997) 1.29
Comparison of different PCR approaches for characterization of Burkholderia (Pseudomonas) cepacia isolates. J Clin Microbiol (1995) 1.28
Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection. Infect Immun (2010) 1.25
Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom. J Clin Microbiol (2000) 1.24
Distribution of quorum-sensing genes in the Burkholderia cepacia complex. Infect Immun (2001) 1.23
Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis. J Bacteriol (2005) 1.20
Clonal population structure of Pseudomonas stutzeri, a species with exceptional genetic diversity. J Bacteriol (2001) 1.19
Identification of IS1356, a new insertion sequence, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients. J Clin Microbiol (1996) 1.16
Attenuated virulence of a Burkholderia cepacia type III secretion mutant in a murine model of infection. Infect Immun (2003) 1.15
Burkholderia cepacia Complex: Emerging Multihost Pathogens Equipped with a Wide Range of Virulence Factors and Determinants. Int J Microbiol (2010) 1.11
Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect Immun (1997) 1.11
Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation. J Clin Microbiol (2002) 1.06
Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy. J Clin Microbiol (2005) 1.02
Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis. J Clin Microbiol (2004) 1.01
Molecular typing of, and distribution of genetic markers among, Burkholderia cepacia complex isolates from Brazil. J Clin Microbiol (2003) 0.96
Improved electrotransformation and decreased antibiotic resistance of the cystic fibrosis pathogen Burkholderia cenocepacia strain J2315. Appl Environ Microbiol (2009) 0.95
Inactivation of macrophage Rab7 by Burkholderia cenocepacia. J Innate Immun (2010) 0.94
Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex. Antimicrob Agents Chemother (2008) 0.94
Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine. Med Microbiol Immunol (2009) 0.94
Identification by subtractive hybridization of a novel insertion element specific for two widespread Burkholderia cepacia genomovar III strains. J Clin Microbiol (2003) 0.93
In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species. Antimicrob Agents Chemother (2008) 0.90
Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks. J Clin Microbiol (1999) 0.86
Intercontinental spread of a highly transmissible clone of Pseudomonas cepacia proved by multilocus enzyme electrophoresis and ribotyping. Can J Infect Dis (1994) 0.84
Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells. Eur J Clin Microbiol Infect Dis (2007) 0.82
Characterization of BCAM0224, a multifunctional trimeric autotransporter from the human pathogen Burkholderia cenocepacia. J Bacteriol (2014) 0.80
Proteome and Secretome Analysis Reveals Differential Post-transcriptional Regulation of Toll-like Receptor Responses. Mol Cell Proteomics (2017) 0.78
SNaPBcen: a novel and practical tool for genotyping Burkholderia cenocepacia. J Clin Microbiol (2013) 0.78
Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex. J Clin Microbiol (2004) 0.77
Genome Sequences of Three Strains of the Pseudomonas aeruginosa PA7 Clade. Genome Announc (2015) 0.77
Burkholderia cenocepacia Lipopolysaccharide Modification and Flagellin Glycosylation Affect Virulence but Not Innate Immune Recognition in Plants. MBio (2015) 0.76
Genomic Rearrangements and Functional Diversification of lecA and lecB Lectin-Coding Regions Impacting the Efficacy of Glycomimetics Directed against Pseudomonas aeruginosa. Front Microbiol (2016) 0.75
Burkholderia cepacia complex in cystic fibrosis in the post-epidemic period: multilocus sequence typing-based approach. Folia Microbiol (Praha) (2017) 0.75
Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol (1986) 24.31
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Multilocus Structure of Natural Populations of HORDEUM SPONTANEUM. Genetics (1980) 7.47
Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet (1993) 7.12
Population genetics of pathogenic bacteria. Microb Pathog (1987) 5.59
Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet (1990) 4.39
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol (1991) 4.20
Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J Clin Microbiol (1992) 3.13
Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr (1988) 2.60
A two-locus neutrality test: applications to humans, E. coli and lodgepole pine. Genetics (1986) 2.34
rRNA gene restriction patterns and plasmid analysis as a tool for typing Salmonella enteritidis. Res Microbiol (1991) 2.27
Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis (1989) 2.25
Subgrouping of Pseudomonas cepacia by cellular fatty acid composition. J Clin Microbiol (1989) 2.23
Microbiology of lung infection in cystic fibrosis. Br Med Bull (1992) 2.22
Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol (1993) 2.15
Optimal data processing procedure for automatic bacterial identification by gas-liquid chromatography of cellular fatty acids. J Clin Microbiol (1988) 2.13
Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol (1993) 2.12
Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol (1990) 1.69
Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. J Clin Microbiol (1993) 1.60
Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Arch Dis Child (1990) 1.55
Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia. J Infect Dis (1991) 1.55
Pseudomonas cepacia--fatal pulmonary infection in a patient with cystic fibrosis. J Infect (1986) 1.40
Complexity of Pseudomonas aeruginosa infection in cystic fibrosis: combined results from esterase electrophoresis and rDNA restriction fragment length polymorphism analysis. Epidemiol Infect (1991) 1.33
Pseudomonas cepacia infection in cystic fibrosis. Lancet (1992) 1.04
Isoenzyme analysis of Pseudomonas cepacia as an epidemiologic tool. Am J Med (1991) 0.95
Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J Clin Microbiol (1990) 5.41
Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction. J Clin Microbiol (1991) 3.32
Genomic fingerprinting of Neisseria meningitidis associated with group C meningococcal disease in Canada. J Clin Microbiol (1993) 3.10
Factors affecting reliability and reproducibility of amplification-based DNA fingerprinting of representative bacterial pathogens. J Clin Microbiol (1997) 2.87
Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis. J Clin Microbiol (1991) 2.78
Comparison of polymerase chain reaction and chlamydiazyme for the detection of Chlamydia trachomatis in clinical specimens. Eur J Clin Microbiol Infect Dis (1992) 2.30
Differentiation of genes coding for Escherichia coli verotoxin 2 and the verotoxin associated with porcine edema disease (VTe) by the polymerase chain reaction. J Clin Microbiol (1990) 2.02
Microbial flora of the mouse ileum mucous layer and epithelial surface. Appl Environ Microbiol (1982) 1.84
A polymerase chain reaction (PCR) protocol for the specific detection of Chlamydia spp. Mol Cell Probes (1989) 1.74
Insecticide and viral interaction as a cause of fatty visceral changes and encephalopathy in the mouse. Lancet (1974) 1.67
Enhanced virus replication in mammalian cells exposed to commercial emulsifiers. Appl Environ Microbiol (1978) 1.66
Lethal interaction of ubiquitous insecticide carriers with virus. Science (1976) 1.65
Oligonucleotide primers designed to differentiate pathogenic pseudomonads on the basis of the sequencing of genes coding for 16S-23S rRNA internal transcribed spacers. Clin Diagn Lab Immunol (1995) 1.61
Passive transfer of HIV antibody by hepatitis B immune globulin. JAMA (1989) 1.53
Antibodies to snowshoe hare virus of the California group in the snowshoe hare (Lepus americanus) population of Nova Scotia. Am J Trop Med Hyg (1978) 1.53
Discriminatory genomic fingerprinting of Legionella pneumophila by pulsed-field electrophoresis. J Clin Microbiol (1994) 1.36
Differentiation of Shiga toxin and Vero cytotoxin type 1 genes by polymerase chain reaction. J Infect Dis (1990) 1.35
Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991. J Clin Microbiol (1992) 1.25
Antibodies to the California group of arboviruses in animal populations of New Brunswick. Can J Microbiol (1982) 1.21
Evaluation of ribotyping as epidemiologic tool for typing Escherichia coli serogroup O157 isolates. J Clin Microbiol (1996) 1.21
Detection of the aerolysin gene in Aeromonas hydrophila by the polymerase chain reaction. J Clin Microbiol (1990) 1.16
Identification of IS1356, a new insertion sequence, and its association with IS402 in epidemic strains of Burkholderia cepacia infecting cystic fibrosis patients. J Clin Microbiol (1996) 1.16
Interferon induced growth depression in diploid and heteroploid human cells. Proc Soc Exp Biol Med (1972) 1.13
Plaque assay for virulent Legionella pneumophila. J Clin Microbiol (1989) 1.08
Enhanced responsiveness of L-929 cells treated with interferon to arginine starvation. Exp Cell Res (1975) 1.07
Interferon inhibition of DNA synthesis and cell division. Can J Microbiol (1972) 0.98
Amplification by the polymerase chain reaction of a specific target sequence in the gene coding for Escherichia coli verotoxin (VTe variant). FEMS Microbiol Lett (1991) 0.96
Emulsifiers that enhance susceptibility to virus infection: increased virus penetration and reduced interferon response. Appl Environ Microbiol (1980) 0.93
A survey of reovirus antibodies in sera of urban children. Can Med Assoc J (1966) 0.93
Detection of genes coding for listeriolysin and Listeria monocytogenes antigen A (ImaA) in Listeria spp. by the polymerase chain reaction. Microb Pathog (1992) 0.92
Is a compromised interferon response an etiologic factor in Reye's syndrome? Can Med Assoc J (1982) 0.90
Immunobiological study of interferon-gamma-producing cells after staphylococcal enterotoxin B stimulation. Immunology (1990) 0.89
Antibodies to the California group of arboviruses in the moose (Alces alces americana Clinton) population of Nova Scotia. Can J Microbiol (1981) 0.89
Antibodies to snowshoe hare virus of the California group in the horse population in Nova Scotia. Can J Microbiol (1980) 0.87
Chloroform inactivation of reovirus hemagglutinins. Can Med Assoc J (1967) 0.84
Production of interferon by peripheral blood mononuclear cells from normal individuals and patients with chronic lymphocytic leukemia. J Interferon Res (1986) 0.83
Immunodiffusion and immunoelectrophoretic studies of reovirus antigens. Can J Microbiol (1968) 0.82
Interferon inhibition of autogenously induced virions (C particles) in synchronized L-929 cell cultures. J Natl Cancer Inst (1974) 0.82
Induction of interferon in hybrid clones: Vero 153--mouse myeloma and Vero 153--human lymphocyte cells. Somatic Cell Genet (1983) 0.82
Effects of antipyretics on mortality due to influenza B virus in a mouse model of Reye's syndrome. Clin Invest Med (1999) 0.81
Interferon-mediated increased lysis of L-cells by vesicular stomatitis virus. Can J Microbiol (1974) 0.80
Colonization of particulates, mucous, and intestinal tissue. Prog Food Nutr Sci (1983) 0.79
Genomic stability of Legionella pneumophila isolates recovered from two cardiac transplant patients with nosocomial Legionnaires' disease. J Clin Microbiol (1994) 0.79
Inhibition of reverse transcriptase by polyvinyl sulfate (PVS). Cancer Biochem Biophys (1981) 0.78
Biochemical and morphological characteristics of a mouse model of Reye's syndrome induced by the interaction of influenza B virus and a chemical emulsifier. Lab Invest (1986) 0.78
The occurrence of hepatitis-associated antigen in a group of Canadian patients with leukemia. Can Med Assoc J (1972) 0.78
Antibodies to snowshoe hare virus of the California group in the snowshoe hare (Lepus americanus) and domestic animal populations of Prince Edward Island. Can J Microbiol (1981) 0.78
8-Azaguanine resistant African green monkey kidney cell mutants (Vero 153): isolation and characterization. In Vitro (1983) 0.77
The characteristics of enhanced DNA synthesis in L cells treated with interferon and arginine-deprived. Exp Cell Res (1977) 0.77
Interferon stimulation of methylase activity in L-cells. Can J Microbiol (1969) 0.77
Variation of interferon production during the cell cycle. Appl Microbiol (1970) 0.76
Differential effect of interferon on glycoprotein and membrane protein of vesicular stomatitis virus released from murine and simian cells. J Interferon Res (1984) 0.76
The intracellular development of vaccinia virus as observed in freeze-etched preparations. Can J Microbiol (1971) 0.76
California encephalitis in Nova Scotia. Can Med Assoc J (1982) 0.75
Application of freeze-etching method to the study of reovirus-infected LLC-MK2 cells. Appl Microbiol (1970) 0.75
The ultrastructure of the reovirus inclusion: a freeze etching study. J Ultrastruct Res (1971) 0.75
Growth and cytopathic effect of rubella virus in primary and progeny guinea pig kidney cells. Am J Clin Pathol (1978) 0.75
Scanning electron microscopy of L-929 cells exposed to interferon and reovirus. Acta Virol (1977) 0.75
Demonstration of primer stimulated DNA synthesis by soluble reverse transcriptase. Arch Virol (1981) 0.75
Production of interferon by peripheral blood mononuclear cells from normal individuals and patients with chronic lymphocytic leukemia. J Interferon Res (1992) 0.75
Influenza B outbreak at a Canadian Forces Base--Nova Scotia. Can Dis Wkly Rep (1988) 0.75
Surfactant-potentiated increases in intracranial pressure in a mouse model of Reye's syndrome. Exp Neurol (1991) 0.75
Isolation and characterisation of the L cell virion DNA polymerase. Arch Virol (1981) 0.75
Morphological and immunological studies on reovirus type 2 hemagglutinin. Arch Gesamte Virusforsch (1968) 0.75
Demonstration of an unusual DNA polymerase activity associated with the L cell virion. J Gen Virol (1979) 0.75
Further observation on interferon production by chronic lymphocytic leukemia cells. Eur J Cancer Clin Oncol (1984) 0.75
HIV-1 infections in the Canadian Atlantic provinces. Can Dis Wkly Rep (1988) 0.75